Literature DB >> 618434

Inhibition of hepatic metabolism of azathioprine in vivo.

N Kaplowitz, J Kuhlenkamp.   

Abstract

Glutathione-mediated thiolysis of azathioprine in the liver is believed to be the main mechanism for the conversion of this drug to 6-mercaptopurine. This metabolic step was inhibited in vivo by pretreating rats with probenecid as indicated both by less hepatic glutathione depletion and by a greater proportion of unmetabolized azathioprine in the liver. Less hepatic gluthathione depletion was also found in the hyperbilirubinemic Gunn rat. These findings indicate that the conversion of azathioprine to 6-mercaptopurine in vovo is mediated enzymatically by the glutathione S-transferases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618434

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway.

Authors:  Sukirti Kalra; Ying Zhang; Elena V Knatko; Stewart Finlayson; Masayuki Yamamoto; Albena T Dinkova-Kostova
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-29

Review 2.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

3.  Pharmacokinetics of bredinin in renal transplant patients.

Authors:  K Takada; S Asada; Y Ichikawa; T Sonoda; S Takahara; S Nagano; T Fukunishi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?

Authors:  Gabriele Stocco; Marco Pelin; Raffaella Franca; Sara De Iudicibus; Eva Cuzzoni; Diego Favretto; Stefano Martelossi; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

5.  Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

Authors:  Christoph Thiel; Henrik Cordes; Isabel Conde; José Vicente Castell; Lars Mathias Blank; Lars Kuepfer
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

6.  Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants.

Authors:  Marianna Lucafò; Gabriele Stocco; Stefano Martelossi; Diego Favretto; Raffaella Franca; Noelia Malusà; Angela Lora; Matteo Bramuzzo; Samuele Naviglio; Erika Cecchin; Giuseppe Toffoli; Alessandro Ventura; Giuliana Decorti
Journal:  Genes (Basel)       Date:  2019-04-04       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.